Publication
Article
Pharmacy Times
A study of 1000 diabetic families identified a new gene mutation?called SUMO-4?as a contributorto juvenile diabetes. The discovery will increase the accuracy of existing newborn diabetesscreening, according to the Juvenile Diabetes Research Foundation. Researchers at the MedicalCollege of Georgia, who found SUMO-4, are conducting a second study that will enroll about 5000children with type 1 diabetes and their relatives. Furthermore, the researchers are screening 40,000newborns in Augusta, Atlanta, and Athens (Ga), and in Aiken (SC) to determine those with high-riskgenes for diabetes. The researchers intend to follow children with such genes for 15 to 20 years.(The findings were reported in Nature Genetics, July 11, 2004.)
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.